Diabetes Mellitus, Type 1: all 3,614 studies
Page 27 of 37. Open to participants first (586), then studies with results posted, then the rest; newest registration first within each.
- Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient SettingCompletedNCT02463682Not applicable
- An Evaluation of Internet-based Carbohydrate Counting Education for Adolescents With Type 1 DiabetesCompletedNCT02462785Not applicable
- Islet Isolation Using MnTE-2-PyP (BMX-010) - Pilot StudyCompletedNCT02457858Phase 1
- A Performance Evaluation of the Harmony 1 Sensors in Adults and PediatricsWithdrawnNCT02456922Not applicable
- Effects of Structured Group Education on Quality of Life and Glycemic Control in Type 1 DiabetesTerminatedNCT02443532Not applicable
- Prebiotic Fiber Supplement in T1DM ChildrenStatus unknownNCT02442544Early Phase 1
- Effects of Low Intensity Aerobic Exercise on the Microvascular Endothelial Function of Patients With Type 1 DiabetesCompletedNCT02441504Not applicable
- MPC Versus PID for Closed Loop Insulin DeliveryCompletedNCT02438670Not applicable
- Development of a Comprehensive AP Training Curriculum for AdultsCompletedNCT02434094
- Pilot Study: Intensive Education in a Residential Camp Setting for Families of Young Children With Type 1 DiabetesCompletedNCT02432586Not applicable
- Three-dimensional Measurements of Diabetic Foot UlcersCompletedNCT02423850
- Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 DiabetesCompletedNCT02423434
- Description of Socio-cognitive and Clinic Changes for Type 1 Diabetes Adolescents Cohort With Therapeutic Patient Education ProgramCompletedNCT02422043Not applicable
- Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 DiabetesCompletedNCT02416765Phase 2
- Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 DiabetesCompletedNCT02411253Phase 2
- Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes SubjectsCompletedNCT02408705Phase 2
- Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune DiabetesCompletedNCT02407899Phase 4
- The Expert System VoiceDiab in Children With DiabetesStatus unknownNCT02403427Not applicable
- Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 DiabetesCompletedNCT02403375Not applicable
- Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study ProtocolCompletedNCT02402439Phase 1
- Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes MellitusCompletedNCT02392117
- Roles of T Helper 1 Cytokines in Type 1 DiabetesCompletedNCT02389335
- DFMO in Children With Type 1 DiabetesCompletedNCT02384889Phase 1
- Changing Diabetes in ChildrenTerminatedNCT02382757
- DiaCon Dual-Hormone Closed-Loop Glucose ControlWithdrawnNCT02379299Phase 2/3
- Hypothalamo-pituitary Adrenal Axis Activity and Neuropsychological Consequences in Type 1 Diabetes in ChildhoodCompletedNCT02377583Not applicable
- User Performance and System Accuracy Evaluations Using Glucose AdjustmentCompletedNCT02374879Not applicable
- What is the Dose Response of Varying Meal Content of Fat on Postprandial Glycaemia in Children With T1DM?CompletedNCT02371694Not applicable
- Islet Transplantation Through an Indwelling Catheter in the Umbilical VeinCompletedNCT02367534Phase 1/2
- Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic OptionsStatus unknownNCT02365740Not applicable
- An Internet Cognitive-Behavioral Intervention for Youth With Type 1 Diabetes - Participation and EfficacyCompletedNCT02361606Not applicable
- Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 DiabetesCompletedNCT02360254
- Continuous Glucose Sensing at the Site of Subcutaneous Insulin AdministrationCompletedNCT02359617Not applicable
- Autologous Immunoregulatory Dendritic Cells for Type 1 Diabetes TherapyWithdrawnNCT02354911Phase 2
- Type 1 Diabetes and the Brain in ChildrenCompletedNCT02351466
- The Lira Pump TrialCompletedNCT02351232Phase 2/3
- Carbohydrate Counting in Children and Adolescents With Type 1 DiabetesCompletedNCT02350374Not applicable
- Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized MealCompletedNCT02344992Phase 1
- The Effect of Uric Acid Lowering in Type 1 DiabetesCompletedNCT02344602Phase 4
- Healthy Eating, Physical Activity, and Glycemic Control in Young Children With T1DCompletedNCT02343146Not applicable
- Adherence Intervention to Promote Optimal Use of Insulin Pumps in Adolescents With Type 1 DiabetesCompletedNCT02333539Not applicable
- Fats And Carbohydrates Quality on Postprandial glycemIc Response in Type 1 DiabetesStatus unknownNCT02330939Not applicable
- Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 DiabetesCompletedNCT02325206Phase 1
- Effect of Sleep Apnea Treatment on Type 1 DiabetesCompletedNCT02316665Not applicable
- Pilot Study of Between Visit Interaction to Improve Glycemic Control in Pregnancy With Pre-existing DiabetesCompletedNCT02315274Not applicable
- The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against HypoglycemiaCompletedNCT02308293Not applicable
- The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 DiabetesStatus unknownNCT02307695Phase 4
- Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin TherapyCompletedNCT02307110Not applicable
- A Survey on Low Blod Sugar Among Insulin-treated Patients With DiabetesCompletedNCT02306681
- Can Gluten-free Diet Prevent the Destruction of Beta-cells During Remission?Status unknownNCT02284815Early Phase 1
- Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal HypoglycemiaCompletedNCT02282254Phase 2
- Lypo-hypertrofia Characterization in DiabetesCompletedNCT02278926
- Normal Versus Dual Wave Insulin Bolus for High-protein FoodCompletedNCT02276859Phase 4
- Children With Diabetes at Risk for Heart Disease.Status unknownNCT02275091
- A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 DiabetesCompletedNCT02273258Phase 1
- Self-management of Type 1 Diabetes Under Functional Insulin TherapyTerminatedNCT02272348Not applicable
- A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)CompletedNCT02269735Phase 1
- Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 DiabetesCompletedNCT02265809Phase 1/2
- CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Cross-Sectional StudyCompletedNCT02258945
- CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Longitudinal StudyCompletedNCT02258932
- Acceptability and Feasibility of an ACT-Based Group to Improve Diabetes Self-ManagementWithdrawnNCT02256293Phase 1/2
- Insulin Bolus Required for High Fat Foods in Type 1 DiabetesCompletedNCT02248454Not applicable
- Influence of Diabetes on Tramadol PharmacokineticsCompletedNCT02246712Phase 4
- Home-Based Interventions for Adolescents With Type 1 DiabetesCompletedNCT02243072Not applicable
- The Multi-Sensor Distance Accuracy StudyCompletedNCT02241993
- Pancreas Volume in Preclinical Type 1 DiabetesCompletedNCT02234947
- Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 DiabetesStatus unknownNCT02232971Phase 4
- A Survey on Hypoglycaemia Among Insulin-treated Patients With DiabetesCompletedNCT02230631
- Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in IndiaCompletedNCT02230618
- Text Message for Adolescents With Poorly Controlled Type 1 DiabetesCompletedNCT02230137Not applicable
- Efficacy of Coordinated Insulin Boluses in Type 1 Diabetic PatientsCompletedNCT02229097Phase 4
- Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self CareStatus unknownNCT02225691Not applicable
- Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense as a Tool for Detection of HypoglycemiaCompletedNCT02225379Not applicable
- A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1CompletedNCT02221323Phase 2
- A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes MellitusCompletedNCT02220296Phase 1
- The Influence of Partial Remission Phase of Type 1 Diabetes on Patient OutcomeStatus unknownNCT02220257
- Edmonton Automated Sugar Intelligence - Intelligent Diabetes Management, EASI-IDM, App Program to Assist Diabetes CareCompletedNCT02214719Not applicable
- Resilient, Empowered, Active Living: REAL Diabetes StudyCompletedNCT02214641Not applicable
- A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 DiabetesCompletedNCT02213146Phase 1/2
- Genetic and Environmental Risk Factors of Type 1 Autoimmune Diabetes and Its Early ComplicationsStatus unknownNCT02212522
- Diabetes Intervention Program for Adolescents With Persistent High HA1cStatus unknownNCT02212158Not applicable
- Dapagliflozin in Type 1 DiabetesCompletedNCT02211742Phase 4
- Post-exercise Appetite Responses in Type 1 DiabetesCompletedNCT02208115Not applicable
- Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes MellitusWithdrawnNCT02206568Phase 1
- Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DMCompletedNCT02204839Not applicable
- Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 MelitisCompletedNCT02204397Phase 2
- Social Determinants in Chronic Disease in British ColumbiaCompletedNCT02203084
- Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With LantusCompletedNCT02201199Phase 1
- β-cell Function in Type 1 Diabetes May Not Be As Low As PresumedCompletedNCT02199470
- Impact of ELKa, the Toolset for Food Exchanges Calculation on Metabolic Control in Pediatric Diabetic Patients.CompletedNCT02194517Not applicable
- Insulin Degludec and Symptomatic Nocturnal HypoglycaemiaCompletedNCT02192450Phase 4
- Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes CampCompletedNCT02189694Phase 2
- T1D Risk Assessment in Kids With RelativesCompletedNCT02184676Not applicable
- Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in ChildrenCompletedNCT02179281Not applicable
- Reducing Distress And Improving Glycemic Control In Adults With Type 1 DiabetesCompletedNCT02175732Not applicable
- A Reinforcement Approach to Improve Diabetes ManagementCompletedNCT02167243Not applicable
- Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic ChildrenCompletedNCT02164279
- Continuous CorrectionTerminatedNCT02162004Not applicable
- Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop FormatCompletedNCT02160275Not applicable
- Nocturnal Insulin-Glucose in Hospital: Tight ControlCompletedNCT02160184Not applicable